{'fraction_non_alphanumeric': 0.035202086049543675, 'fraction_numerical': 0.00651890482398957, 'mean_word_length': 5.4, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Clinical Reasoning: A 45-year-old man with acute onset of multifocal weakness and paresthesias

A 45-year-old man with epilepsy and immunoglobulin G (IgG) κ multiple myeloma (MM) diagnosed a year ago presented to the neurology clinic with right hand weakness and paresthesias, painless proximal left arm weakness, and paresthesias in the right foot. Symptoms began acutely over a 2-week period in the setting of a diffuse nonpruritic rash. The patient had undergone an allogenic hematopoietic stem cell transplant (HSCT) a month prior due to suboptimal response to bortezomib, cyclophosphamide, etoposide, cisplatin, carfilzomib, and autologous stem cell transplant. He denied headaches, neck pain, radicular symptoms, bladder or bowel dysfunction, or gait imbalance.